Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
MyChesCo on MSN1 个月
Windtree Therapeutics Begins SEISMiC C Trial for Advanced Cardiogenic Shock(NasdaqCM: WINT) has initiated patient enrollment for its SEISMiC C trial, targeting SCAI Stage C cardiogenic shock. This ...
MyChesCo on MSN4 个月
Windtree Therapeutics Reports Second-Quarter Financial Results and Key Business Updateswe plan to accelerate enrollments in the istaroxime SCAI Stage C cardiogenic shock study as well as provide guidance on our ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈